Ancora.ai is an AI-enabled, digital clinical trial recruitment platform connecting patients to clinical trials.
Ancora.ai has raised $33K in total funding. The most recent round was Grant. The last funding was announced in February 2023.
Ancora.ai's investors include Google for Startups, Almirall, EIT Health, Future of Health Grant.
Ancora.ai is headquartered in Zürich, Switzerland.
Ancora.ai is an AI-enabled, digital clinical trial recruitment platform connecting patients to clinical trials.
Ancora.ai is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ancora.ai — Funding & Investors." VCBacked, February 9, 2023, https://www.vcbacked.co/company/ancoraai. Accessed September 16, 2026.
VCBacked. (2023). Ancora.ai — Funding & Investors. Retrieved September 16, 2026, from https://www.vcbacked.co/company/ancoraai
{{cite web |title=Ancora.ai — Funding & Investors |url=https://www.vcbacked.co/company/ancoraai |website=VCBacked |access-date=September 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated